Correlation Between Fortress Biotech and Sangamo Therapeutics

Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Fortress Biotech and Sangamo Therapeutics, you can compare the effects of market volatilities on Fortress Biotech and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Sangamo Therapeutics.

Diversification Opportunities for Fortress Biotech and Sangamo Therapeutics

0.34

Correlation Coefficient

Fortress Biotech  Sangamo Therapeutics

Weak diversification

The 3 months correlation between Fortress and Sangamo is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Sangamo Therapeutics go up and down completely randomly.

Pair Corralation between Fortress Biotech and Sangamo Therapeutics

Given the investment horizon of 90 days Fortress Biotech is expected to generate 0.33 times more return on investment than Sangamo Therapeutics. However, Fortress Biotech is 3.03 times less risky than Sangamo Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Sangamo Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  218.00  in Fortress Biotech on December 29, 2024 and sell it today you would lose (45.00) from holding Fortress Biotech or give up 20.64% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Fortress Biotech  vs.  Sangamo Therapeutics

Fortress Biotech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Fortress Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sangamo Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sangamo Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Fortress Biotech and Sangamo Therapeutics

The main advantage of trading using opposite Fortress Biotech and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.

The idea behind Fortress Biotech and Sangamo Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.